Your session is about to expire
← Back to Search
Sling Device
AdVance for Stress Incontinence
N/A
Waitlist Available
Research Sponsored by Jewish General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
The study is designed to assess efficacy and subject satisfaction of two sling devices: Advance and Argus, in male patients with stress urinary incontinence after prostatectomy.
Eligible Conditions
- Stress Incontinence
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient satisfaction using the Patient Global Impression of Improvement (PGI-I) score and assess change in 24-hour pad weight .
Secondary outcome measures
Assess change in subject satisfaction using questionnaires: ICIQ, UCLA-RAND Incontinence Index.
Other outcome measures
Summarize all cumulative device and procedure related adverse events
Trial Design
2Treatment groups
Active Control
Group I: AdVanceActive Control1 Intervention
sling procedure
Group II: ARGUSActive Control1 Intervention
sling procedure
Find a Location
Who is running the clinical trial?
Jewish General HospitalLead Sponsor
137 Previous Clinical Trials
271,916 Total Patients Enrolled
Center Hospitalier de Fleurimont,Sherbrooke UniversityUNKNOWN
Sunnybrook Health Sciences CentreOTHER
656 Previous Clinical Trials
1,551,180 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger